These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34913067)

  • 1. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
    Shimizu S; Kawahara R; Simizu S
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34913067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine aminopeptidase 2 is required for HSC initiation and proliferation.
    Ma AC; Fung TK; Lin RH; Chung MI; Yang D; Ekker SC; Leung AY
    Blood; 2011 Nov; 118(20):5448-57. PubMed ID: 21937698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
    Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
    Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.
    Catalano A; Romano M; Robuffo I; Strizzi L; Procopio A
    Am J Pathol; 2001 Aug; 159(2):721-31. PubMed ID: 11485930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
    Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitroxoline on angiogenesis and growth of human bladder cancer.
    Shim JS; Matsui Y; Bhat S; Nacev BA; Xu J; Bhang HE; Dhara S; Han KC; Chong CR; Pomper MG; So A; Liu JO
    J Natl Cancer Inst; 2010 Dec; 102(24):1855-73. PubMed ID: 21088277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
    Esa R; Steinberg E; Dror D; Schwob O; Khajavi M; Maoz M; Kinarty Y; Inbal A; Zick A; Benny O
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity.
    Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK
    ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
    Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
    Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
    Wang J; Lou P; Henkin J
    J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Characterization of SDX-7320/Evexomostat: A Novel Methionine Aminopeptidase Type 2 Inhibitor with Anti-tumor and Anti-metastatic Activity.
    Cornelius P; Mayes BA; Petersen JS; Turnquist DJ; Dufour PJ; Dannenberg AJ; Shanahan JM; Carver BJ
    Mol Cancer Ther; 2024 May; 23(5):595-605. PubMed ID: 38530115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470.
    Alvarado JJ; Nemkal A; Sauder JM; Russell M; Akiyoshi DE; Shi W; Almo SC; Weiss LM
    Mol Biochem Parasitol; 2009 Dec; 168(2):158-67. PubMed ID: 19660503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
    Klein CD; Folkers G
    Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of methionine aminopeptidase 2 does not alter cell response to fumagillin or bengamides.
    Kim S; LaMontagne K; Sabio M; Sharma S; Versace RW; Yusuff N; Phillips PE
    Cancer Res; 2004 May; 64(9):2984-7. PubMed ID: 15126329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
    Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
    Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.
    Brdlik CM; Crews CM
    J Biol Chem; 2004 Mar; 279(10):9475-80. PubMed ID: 14676204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsporidian methionine aminopeptidase type 2.
    Weiss LM; Costa SF; Zhang H
    J Eukaryot Microbiol; 2001; Suppl():88S-90S. PubMed ID: 11906093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.